组蛋白去乙酰化酶抑制剂在癌症治疗中的应用 - Suppr

Suppr

超能文献

Histone deacetylase inhibitors in cancer therapy.

作者信息

Fouladi Maryam

机构信息

Department of Hematology-Oncology, St Jude Children's Research Hospital, Memphis, TN 38105-2794, USA.

出版信息

Cancer Invest. 2006 Aug-Sep;24(5):521-7. doi: 10.1080/07357900600814979.

DOI:10.1080/07357900600814979

PMID:16939962

Abstract

摘要

相似文献

Histone deacetylase inhibitors in cancer therapy.

Cancer Invest. 2006 Aug-Sep;24(5):521-7. doi: 10.1080/07357900600814979.

Molecule of the month. Vorinostat.

Drug News Perspect. 2006 Jul-Aug;19(6):352.

Histone post-translational modification: from discovery to the clinic.

IDrugs. 2006 Jun;9(6):398-401.

[A new target of cancer therapy: advances in the study of histone deacetylase].

Yao Xue Xue Bao. 2005 Jul;40(7):585-90.

Clinical studies of histone deacetylase inhibitors.

Clin Cancer Res. 2009 Jun 15;15(12):3958-69. doi: 10.1158/1078-0432.CCR-08-2785. Epub 2009 Jun 9.

Histone deacetylase inhibitors in lymphoma and solid malignancies.

Expert Rev Anticancer Ther. 2008 Mar;8(3):413-32. doi: 10.1586/14737140.8.3.413.

[Progress in cancer treatment with histone deacetylase inhibitor].

Zhonghua Zhong Liu Za Zhi. 2013 Jul;35(7):481-5.

Histone deacetylase inhibitors as anti-neoplastic agents.

Cancer Lett. 2009 Aug 8;280(2):192-200. doi: 10.1016/j.canlet.2009.03.013. Epub 2009 Apr 3.

Molecular basis of the anti-cancer effects of histone deacetylase inhibitors.

Int J Biochem Cell Biol. 2009 Jan;41(1):16-20. doi: 10.1016/j.biocel.2008.07.020. Epub 2008 Aug 12.

Histone deacetylase inhibitors: overview and perspectives.

Mol Cancer Res. 2007 Oct;5(10):981-9. doi: 10.1158/1541-7786.MCR-07-0324.

引用本文的文献

GM101 in Combination with Histone Deacetylase Inhibitor Enhances Anti-Tumor Effects in Desmoplastic Microenvironment.

Cells. 2021 Oct 20;10(11):2811. doi: 10.3390/cells10112811.

Sirtuin 6 Attenuates Kaposi's Sarcoma-Associated Herpesvirus Reactivation by Suppressing Ori-Lyt Activity and Expression of RTA.

J Virol. 2019 Mar 21;93(7). doi: 10.1128/JVI.02200-18. Print 2019 Apr 1.

Lighting a Fire in the Tumor Microenvironment Using Oncolytic Immunotherapy.

EBioMedicine. 2018 May;31:17-24. doi: 10.1016/j.ebiom.2018.04.020. Epub 2018 Apr 23.

Identification of HDAC6-Selective Inhibitors of Low Cancer Cell Cytotoxicity.

ChemMedChem. 2016 Jan 5;11(1):81-92. doi: 10.1002/cmdc.201500456. Epub 2015 Nov 23.

Synthesis and biological evaluation of largazole analogues with modified surface recognition cap groups.

Eur J Med Chem. 2014 Oct 30;86:528-41. doi: 10.1016/j.ejmech.2014.09.009. Epub 2014 Sep 6.

How can we trick the immune system into overcoming the detrimental effects of oncolytic viral therapy to treat glioblastoma?

Expert Rev Neurother. 2013 Apr;13(4):341-3. doi: 10.1586/ern.13.25.

The histone deacetylase inhibitor valproic acid lessens NK cell action against oncolytic virus-infected glioblastoma cells by inhibition of STAT5/T-BET signaling and generation of gamma interferon.

J Virol. 2012 Apr;86(8):4566-77. doi: 10.1128/JVI.05545-11. Epub 2012 Feb 8.

(Bis)urea and (bis)thiourea inhibitors of lysine-specific demethylase 1 as epigenetic modulators.

J Med Chem. 2010 Jul 22;53(14):5197-212. doi: 10.1021/jm100217a.

Histone deacetylase inhibitors: current status and overview of recent clinical trials.

Drugs. 2009 Oct 1;69(14):1911-34. doi: 10.2165/11315680-000000000-00000.

Mechanistic studies on the effects of nicotinamide on megakaryocytic polyploidization and the roles of NAD+ levels and SIRT inhibition.

Exp Hematol. 2009 Nov;37(11):1340-1352.e3. doi: 10.1016/j.exphem.2009.08.004. Epub 2009 Aug 26.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验